Levroxa 500mg Tablet contains Levetiracetam 500mg, an antiepileptic medication primarily used to treat partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, which is believed to inhibit burst firing and reduce neuronal excitability. This mechanism contributes to its efficacy in controlling seizures. Levroxa is indicated as adjunctive therapy for epilepsy in adults and pediatric patients aged one month and older. The medication is typically administered orally, with dosage individualized based on patient response and clinical condition. Common side effects may include dizziness, somnolence, headache, and fatigue, though it is generally well tolerated. Caution is advised in patients with renal impairment, and dose adjustments may be necessary. Levroxa should be used under medical supervision, with regular monitoring to assess therapeutic response and detect potential adverse effects. Abrupt discontinuation is discouraged due to the risk of increased seizure frequency. Overall, Levroxa 500mg Tablet offers a valuable option in the management of various seizure disorders, contributing to improved patient quality of life through effective seizure control.